Zobrazeno 1 - 10
of 216 632
pro vyhledávání: '"multiple myeloma."'
Autor:
O'Donnell EK; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: Elizabeth_odonnell@dfci.harvard.edu., Borden BA; Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA., Ghobrial IM; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2024 Aug; Vol. 38 (4), pp. 743-753. Date of Electronic Publication: 2024 May 09.
Autor:
Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rasche L; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Mildred Scheel Early Career Center, Universitätsklinikum Würzburg, Würzburg, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4263-4265.
Autor:
Schmidt T; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI., Gahvari Z; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI., Callander NS; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI. Electronic address: nsc@medicine.wisc.edu.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. 653-664. Date of Electronic Publication: 2024 Mar 16.
Autor:
Kazandjian D; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Hill E; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Chojnacka M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Durante M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Young R; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Davies F; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ghobrial I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4482-4490.
Autor:
Kumar S; The Mayo Clinic, Rochester, MN, USA., Rajkumar SV; The Mayo Clinic, Rochester, MN, USA., Jevremovic D; The Mayo Clinic, Rochester, MN, USA., Kyle RA; The Mayo Clinic, Rochester, MN, USA., Shifrin Y; Telo Genomics Corp, Toronto, Ontario, Canada., Nguyen M; Telo Genomics Corp, Toronto, Ontario, Canada., Husain Z; Telo Genomics Corp, Toronto, Ontario, Canada., Alikhah A; Telo Genomics Corp, Toronto, Ontario, Canada., Jafari A; Telo Genomics Corp, Toronto, Ontario, Canada., Mai S; University of Manitoba, Winnipeg, Manitoba, Canada., Anderson K; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Louis S; Telo Genomics Corp, Toronto, Ontario, Canada.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug; Vol. 99 (8), pp. 1532-1539. Date of Electronic Publication: 2024 May 15.
Autor:
Werly A; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hampel M; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zuern K; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Schmidt SK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Visram A; Division of Haematology, The Ottawa Hospital, Ottawa, Canada., Raab MS; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Mueller-Tidow C; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 14; Vol. 14 (1), pp. 176. Date of Electronic Publication: 2024 Oct 14.
Autor:
Mateos MV; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca, Spain., Martínez-López J; Hematology Department, Hospital 12 de Octubre, Medicine Department, Medicine School of Complutense University, I+12. CNIO, Madrid, Spain., Rodriguez Otero P; Hematology Department, Cancer Center Clinica Universidad de Navarra (CCUN), Cima, CIBERONC, Pamplona, Spain., González-Calle V; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Gonzalez MS; Hematology Department, Hospital Clinico Universitario Santiago de Compostela, Santiago de Compostela, Spain., Oriol A; Clinical Hematology, Institut Català d'Oncologia and Josep Carreras Research Institute, Hospital Germans Trias I Pujol, Badalona, Spain., Gutiérrez NC; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Ríos-Tamayo R; Unidad de Gammapatías Monoclonales, Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Rosiñol L; Hematology Department, Hospital Clinic, Barcelona, Spain., Alvarez Rivas MA; Servicio de Hematología y Hemoterapia, Hospital Universitario Reina Sofía, Córdoba, Spain., Bargay J; Hematology Department, Hospital Universitario Son Llatzer, IdISBa (Institut d'Investigació Sanitaria Illes Balears), Palma, Spain., Gonzalez-Rodriguez AP; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Alegre A; Hematology Department, University Hospital La Princesa & University Hospital QuironSalud, Autonoma-University, Madrid, Spain., Escalante F; Servicio de Hematología, Unidad i+i, Complejo Asistencial Universitario de León, León, Spain., Iñigo Rodríguez MB; Hematology Department, Hospital Clínico San Carlos, Madrid, Spain., De La Rubia J; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Universidad Católica de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC CB16/12/00284, Instituto de Salud Carlos III, Madrid, Spain., Teruel AI; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., de Arriba F; Servicio de Hematologia, Hospital Universitario Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia, Spain., Palomera L; Hematology Department, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain., Hernández MT; Hematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Lopez Jiménez J; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain., Reinoso-Segura M; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain., García Mateo A; Hematology Department, Complejo Asistencial de Segovia, Segovia, Spain., Ocio EM; Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain., Paiva B; Hematology Department, Clinica Universidad de Navarra, Pamplona, Spain., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain., Bladé J; Hematology Department, Hospital Clinic, IDIBARS, Barcelona, Spain., Lahuerta JJ; Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain., San-Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), CIMA, IDISNA, CIBERONC, Pamplona, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 20; Vol. 42 (27), pp. 3247-3256. Date of Electronic Publication: 2024 Jul 22.
Autor:
Xiao HJ; Department of Clinical Laboratory, The 910th Hospital of the Joint Logistics Support Force, Quanzhou 362000, Fujian Province, China., Wang QJ; Department of Clinical Laboratory, The 910th Hospital of the Joint Logistics Support Force, Quanzhou 362000, Fujian Province, China., Wu S; Department of Clinical Laboratory, The 910th Hospital of the Joint Logistics Support Force, Quanzhou 362000, Fujian Province, China., Dai XB; Department of Clinical Laboratory, The 910th Hospital of the Joint Logistics Support Force, Quanzhou 362000, Fujian Province, China., Zhuang YP; Department of Clinical Laboratory, The 910th Hospital of the Joint Logistics Support Force, Quanzhou 362000, Fujian Province, China.E-mail: zyp525@sohu.com.
Publikováno v:
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Aug; Vol. 32 (4), pp. 1146-1151.
Autor:
Bergman Z; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, 419 Redwood Street, Suite 420, Baltimore, MD, 21201, USA., Mohammed T; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, 419 Redwood Street, Suite 420, Baltimore, MD, 21201, USA. mohammed.taariq@gmail.com., Schocket L; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, 419 Redwood Street, Suite 420, Baltimore, MD, 21201, USA., Aouchiche R; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, 419 Redwood Street, Suite 420, Baltimore, MD, 21201, USA., Johnson MA; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, 419 Redwood Street, Suite 420, Baltimore, MD, 21201, USA.
Publikováno v:
Documenta ophthalmologica. Advances in ophthalmology [Doc Ophthalmol] 2024 Jun; Vol. 148 (3), pp. 167-171. Date of Electronic Publication: 2024 Feb 16.
Autor:
Avet-Loiseau H; IUC-T Oncopole, Unité de Génomique du Myélome, Toulouse, France., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.
Publikováno v:
Blood [Blood] 2024 May 16; Vol. 143 (20), pp. 2025-2028.